329 / 329 matched
1-20 displayed (out of 329 matched)
1PROSTAGLANDIN A1 /7-[2(R)-(3(S)-Hydroxy-1(E)-octenyl)-5-oxo-3-cyclopenten-1(R)-yl]heptanoic acid / (8R,12S,13E,15S)-15-Hydroxy-9-oxo-10,13-prostadienoic acid
(No = XPR1000)
2PROSTAGLANDIN A2 /7-[2(R)-(3(S)-Hydroxy-1(E)-octenyl)-5-oxo-3-cyclopenten-1(R)-yl]-5(Z)-heptenoic acid
(No = XPR1001)
319-HYDROXY-PROSTAGLANDIN A2 /7-[2(R)-(3(S),7-Dihydroxy-1(E)-octenyl)-5-oxo-3-cyclopenten-1(R)-yl]-5(Z)-heptenoic acid / 15(S),19-Dihydroxy-9-oxo-8(12),13-trans-prostadienoic acid
(No = XPR1031)
4PROSTAGLANDIN B1 /7-[2-(3(S)-Hydroxy-1(E)-octenyl)-5-oxo-1-cyclopenten-1-yl]heptanoic acid / (E,S)-15-Hydroxy-9-oxo-8(12),13-prostadienoic acid
(No = XPR1100)
5PROSTAGLANDIN B2 /7-[2-(3(S)-Hydroxy-1(E)-octenyl)-5-oxo-1-cyclopenten-1-yl]-5(Z)-heptenoic acid
(No = XPR1101)
619-HYDROXY-PROSTAGLANDIN B2 /7-[2-(3(S),7-Dihydroxy-1(E)-octenyl)-5-oxo-1-cyclopenten-1-yl]-5(Z)-heptenoic acid / 15(S),19-Dihydroxy-9-oxo-5-cis-8(12),13-trans-prostatrienoic acid
(No = XPR1131)
7PROSTAGLANDIN C2 /7-[2-(3(S)-Hydroxy-1(E)-octenyl)-5-oxo-2-cyclopenten-1(R)-yl]-5(Z)-heptenoic acid
(No = XPR1201)
8PROSTAGLANDIN D2 /7-[5(S)-Hydroxy-2(R)-(3(S)-hydroxy-1(E)-octenyl)-3-oxocyclopentan-1(R)-yl]-5(Z)-heptenoic acid
(No = XPR1301)
9PROSTAGLANDIN E1 /7-[3(R)-Hydroxy-2(R)-(3(S)-hydroxy-1(E)-octenyl)-5-oxocyclopentan-1(R)-yl]-heptanoic acid / (8R,11R,12R,13E,15S)-11,15-Dihydroxy-9-oxo-13-prostenoic acid
(No = XPR1400)
10Prostaglandin E2 /7-[3(R)-Hydroxy-2(R)-(3(S)-hydroxy-1(E)-octenyl-5-oxocyclopentan-1(R)-yl]-5(Z)-heptenoic acid
(No = XPR1401)
11PROSTAGLANDIN E3 /7-[3(R)-Hydroxy-2(R)-(3(S)-hydroxyocta-1(E),5(Z)-dienyl)-5-oxocyclopentan-1(R)-yl]-5(Z)-heptenoic acid / (5Z,8R,11R,12R,13E,15S,17Z)-11,15-Dihydroxy-9-oxo-5,13,17-prostatrienoic acid
(No = XPR1402)
1215-KETOPROSTAGLANDIN E2 /7-[3(R)-Hydroxy-2(R)-(3-oxo-1(E)-octenyl)-5-oxocyclopentan-1(R)-yl]-5(Z)-heptenoic acid
(No = XPR1411)
13PROSTAGLANDIN E-MAJOR URINARY METABOLITE /8-[2(R)-(2-Carboxyethyl)-5(R)-hydroxy-3-oxocyclopentan-1(R)-yl]-6-oxooctanoic acid
(No = XPR1421)
146-KETO-PROSTAGLANDIN E1 /7-[3(R)-Hydroxy-2(R)-(3(S)-hydroxy-1(E)-octenyl)-5-oxocyclopentan-1(R)-yl]-6-oxoheptanoic acid
(No = XPR1430)
15PROSTAGLANDIN F1a /7-[3(R),5(S)-Dihydroxy-2(R)-(3(S)-hydroxy-1(E)-octenyl)cyclopentan-1(R)-yl]-heptanoic acid / (8R,9S,11R,13E,15S)-9,11,15-Trihydroxyprost-13-enoic acid
(No = XPR1500)
16PROSTAGLANDIN F2a /7-[3(R),5(S)-Dihydroxy-2(R)-(3(S)-hydroxy-1(E)-octenylcyclopentan-1(R)-yl]-5(Z)-heptenoic acid
(No = XPR1501)
17PROSTAGLANDIN F3a /7-[3(R),5(S)-Dihydroxy-2(R)-(3(S)-hydroxyocta-1(E),5(Z)-dienyl)cyclopentan-1(R)-yl]-5(Z)-heptenoic acid / (5Z,8R,9S,11R,12R,13E,15S,17Z)-9,11,15-Trihydroxyprosta-5,13,17-trienoic acid
(No = XPR1502)
1815-KETOPROSTAGLANDIN F2a /7-[3(R),5(S)-Dihydroxy-2(R)-(3-oxo-1(E)-octenyl)cyclopentan-1(R)-yl]-5(Z)-heptenoic acid
(No = XPR1511)
19PROSTAGLANDIN Fa-MAJOR URINARY METABOLITE /8-[2(R)-(2-Carboxyethyl)-3(S),5(R)-dihydroxycyclopentan-1(R)-yl]-6-oxooctanoic acid
(No = XPR1521)
20PROSTAGLANDIN G2 /7-[2(R)-(3(S)-Hydroperoxy-1(E)-octenyl)-1(R),4(S)-5,6-dioxabicyclo[2.2.1]-heptan-3(R)-yl]-5(Z)-heptenoic acid
(No = XPR1601)

Last updated June 19, 2007. Copyright © 1989-2007 Japanese Conference on the Biochemistry of Lipids (JCBL). All rights reserved.